Serum α1-antichymotrypsin level as a marker for Alzheimer-type dementia
- 1 September 1995
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 16 (5), 747-753
- https://doi.org/10.1016/0197-4580(95)00056-k
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Population-based norms for the Mini-Mental State Examination by age and educational levelJAMA, 1993
- Variants of α1-Antitrypsin in Puerto Rican Children With AsthmaChest, 1993
- Serological α1‐Antichymotrypsin in Down's syndrome and Alzheimer's diseaseAnnals of Neurology, 1992
- Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment CentersNeurology, 1992
- Clinical Genetics and Genetic Counseling in Alzheimer DiseaseAnnals of Internal Medicine, 1991
- Profile of bronchospastic disease in Puerto Rican patients in New York City. A possible relationship to alpha 1-antitrypsin variantsArchives of Internal Medicine, 1990
- Critical analysis of the use of computer‐assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer typeNeurology, 1990
- α1-Antichymotrypsin is associated solely with amyloid deposits containing the β-protein. Amyloid and cell localization of α1-antichymotrypsinNeurobiology of Aging, 1990
- NORMAL AGEING, IMPAIRED COGNITIVE FUNCTION, AND SENILE DEMENTIA OF THE ALZHEIMER'S TYPE: A CONTINUUM?The Lancet, 1988
- Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's diseaseCell, 1988